Get access

Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3β, tau and neuroinflammation

Authors

  • Juliana Bender Hoppe,

    1. Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author
  • Rudimar Luiz Frozza,

    1. Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author
  • Ana Paula Horn,

    1. Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author
  • Ricardo Argenta Comiran,

    1. Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author
  • Andressa Bernardi,

    1. Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author
  • Maria Martha Campos,

    1. Faculdade de Odontologia e Instituto de Toxicologia, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author
  • Ana Maria Oliveira Battastini,

    1. Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author
  • Christianne Salbego

    1. Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
    Search for more papers by this author

Address reprint request to C. Salbego, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Av. Ramiro Barcelos, 2600 – Anexo I, 90035-003, Porto Alegre, Rio Grande do Sul, Brazil.
E-mail: salbego@terra.com.br

Abstract

Abstract:  Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by accumulation of extracellular deposits of amyloid-β (Aβ) peptide in brain regions that are important for memory and cognition. The buildup of Aβ aggregates in the AD is followed by the formation of intracellular neurofibrillary tangles and activation of neuroinflammatory reactions. The present study investigated whether melatonin possesses a neuroprotective effect against Aβ-induced toxicity. For this purpose, organotypic hippocampal slices were cultured and exposed to 25 μm of Aβ25–35 in the absence or in the presence of melatonin (25, 50, or 100 μm). In addition, the authors have investigated the involvement of GSK-3β, tau protein, astroglial, and microglial activation, and cytokine levels in the melatonin protection against Aβ-induced neurotoxicity. Melatonin prevented the cell damage in hippocampus induced by the exposure to Aβ25–35. In addition, melatonin significantly reduced the activation of GSK-3β, the phosphorylation of tau protein, the glial activation and the Aβ-induced increase of TNF-α and IL-6 levels. On the basis of these findings, we speculate that melatonin may provide an effective therapeutic strategy for AD, by attenuating Aβ-induced phosphorylation of tau protein, and preventing GSK-3β activation and neuroinflammation.

Ancillary